ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2504

The Validation of Istanbul  Back Disability Index (IBDI) in Axial Spondyloarthritis Patients

Tuncay Duruoz, Hatice Sule Baklacioglu, Sevtap Acer Kasman and Didem Erdem, PMR Department, Rheumatology Division, Marmara University School of Medicine, Istanbul, Turkey

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: axial spondyloarthritis, Disability, functional status, low back pain and outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster III: Outcomes, Outcome Measures, and Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The IBDI was developed to assess the disability in patients with mechanical low back pain (1) which contains the 18 daily activities questions. The main symptom in Axial Spondyloarthritis (Ax-SpA) is inflammatory back pain which makes patient disabled in daily living. To assess the functional disability concerning to inflammatory back pain is important for accurate clinical approach to patients in daily practice. The aim of this study is to investigate the validation of Istanbul Back Disability Index (IBDI) in Ax-SpA patients.

Methods: The patients with Ax-SpA according to ASAS criteria were recruited into the study. Demographic, clinical and functional characteristics of patients were evaluated. Face and content validities were assessed via cognitive debriefing interviews with Ax-SpA patients. Classical psychometrics assessed, convergent validity (correlation of IBDI with Dougados Functional Index (DFI), Health Assessment Questionnaire (HAQ), ASAS Health Index (ASAS-HI), BASDAI, BASFI) and discriminative validity (correlation of IBDI with disease duration (month), Body Mass Index (BMI), Schöber’s test (cm), finger-floor distance (cm), tragus-wall distance (cm), chest expension (cm), MASES enthesitis score,). Spearman’s correlation coefficient was used to assess the relation between quantitative variables. The SPSS 24.0 statistical package was used for analysis. P<0.05 was accepted as significant.

Results: Sixty patients (37 male, 23 female) with mean of age 39.18 (SD:8.95) years were recruited. The 43.3 % of patients were smoking. The mean of disease duration was 85.93 (SD:79,06) months and the mean of BMI was 26.98 (SD: 4.18) kg/m2. The means of BASDAI and the BASFI were 4,49 (SD: 2,37) and 2,83 (SD: 2,67) respectively. Cognitive debriefing showed the IBDI to be clear, relevant, and comprehensive which shows its face and content validity. The IBDI has good correlation with DFI (rho: 0,809; p<0,0001), HAQ (rho: 0,770; p<0,0001), ASAS-HI (rho:0,673; p<0,0001), BASDAI (rho:0,572; p<0,0001) and BASFI (rho:0,821; p<0,0001). This results show that IBDI has good convergent validity. The IBDI has not significant correlation with non functional parameters such as disease duration (rho: 0,202; p:0,121), BMI (rho: -0,142; p:0,280), Schöber’s test (rho:-0,150; p:0,252), finger-floor distance (rho: 0,189; p:0,149), tragus-wall distance (rho: 0,157; p:0,230), chest expension (rho: -0,232; p:0,075) and MASES (rho: 0,168; p:0,200). These results show that IBDI has discriminative validity.

Conclusion: The IBDI is practical, accurate and not time consuming scale which is valid to evaluate the functional disability in patients with Axial Spondyloarthritis.

(1) Duruöz MT et al. Development and validation of a functional disability index for chronic low back pain. J Back Musculoskelet Rehabil 2013;26:45-54.


Disclosure: T. Duruoz, Abbvie, 2,Sanovel, 6; H. S. Baklacioglu, None; S. Acer Kasman, None; D. Erdem, None.

To cite this abstract in AMA style:

Duruoz T, Baklacioglu HS, Acer Kasman S, Erdem D. The Validation of Istanbul  Back Disability Index (IBDI) in Axial Spondyloarthritis Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-validation-of-istanbul-back-disability-index-ibdi-in-axial-spondyloarthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-validation-of-istanbul-back-disability-index-ibdi-in-axial-spondyloarthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology